CN113318043A - 一种具有固发、生发功效的精华液及其制备方法 - Google Patents
一种具有固发、生发功效的精华液及其制备方法 Download PDFInfo
- Publication number
- CN113318043A CN113318043A CN202110562477.9A CN202110562477A CN113318043A CN 113318043 A CN113318043 A CN 113318043A CN 202110562477 A CN202110562477 A CN 202110562477A CN 113318043 A CN113318043 A CN 113318043A
- Authority
- CN
- China
- Prior art keywords
- hair
- phase
- component
- growing
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004209 hair Anatomy 0.000 title claims abstract description 75
- 230000000694 effects Effects 0.000 title claims abstract description 49
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 35
- 230000003779 hair growth Effects 0.000 claims abstract description 25
- 241000196324 Embryophyta Species 0.000 claims abstract description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000003906 humectant Substances 0.000 claims abstract description 11
- 239000002904 solvent Substances 0.000 claims abstract description 11
- YPFDHNVEDLHUCE-UHFFFAOYSA-N propane-1,3-diol Chemical compound OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 claims abstract description 10
- 238000005728 strengthening Methods 0.000 claims abstract description 10
- 239000002260 anti-inflammatory agent Substances 0.000 claims abstract description 9
- 229940121363 anti-inflammatory agent Drugs 0.000 claims abstract description 9
- 230000003266 anti-allergic effect Effects 0.000 claims abstract description 8
- 239000003961 penetration enhancing agent Substances 0.000 claims abstract description 8
- 239000003755 preservative agent Substances 0.000 claims abstract description 7
- 244000124209 Crocus sativus Species 0.000 claims abstract description 6
- 235000015655 Crocus sativus Nutrition 0.000 claims abstract description 6
- 230000002335 preservative effect Effects 0.000 claims abstract description 6
- 125000003118 aryl group Chemical group 0.000 claims abstract description 5
- 239000002562 thickening agent Substances 0.000 claims abstract description 5
- 241001149649 Taxus wallichiana var. chinensis Species 0.000 claims abstract description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 12
- 238000001816 cooling Methods 0.000 claims description 9
- 238000003756 stirring Methods 0.000 claims description 9
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims description 7
- 244000163122 Curcuma domestica Species 0.000 claims description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 6
- 235000011187 glycerol Nutrition 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 claims description 5
- 235000013399 edible fruits Nutrition 0.000 claims description 5
- 230000001737 promoting effect Effects 0.000 claims description 5
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 4
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 claims description 4
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims description 4
- 244000119298 Emblica officinalis Species 0.000 claims description 4
- 235000015489 Emblica officinalis Nutrition 0.000 claims description 4
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 claims description 4
- 229920002125 Sokalan® Polymers 0.000 claims description 4
- 125000002511 behenyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 4
- 229960001631 carbomer Drugs 0.000 claims description 4
- 229920006037 cross link polymer Polymers 0.000 claims description 4
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 claims description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- YLGYACDQVQQZSW-UHFFFAOYSA-N n,n-dimethylprop-2-enamide Chemical compound CN(C)C(=O)C=C YLGYACDQVQQZSW-UHFFFAOYSA-N 0.000 claims description 4
- 229940104261 taurate Drugs 0.000 claims description 4
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 4
- 235000014375 Curcuma Nutrition 0.000 claims description 3
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 3
- APZYKUZPJCQGPP-UHFFFAOYSA-N Tetrahydropiperine Chemical compound C=1C=C2OCOC2=CC=1CCCCC(=O)N1CCCCC1 APZYKUZPJCQGPP-UHFFFAOYSA-N 0.000 claims description 3
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 3
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 3
- XLELDISCQSKJES-IPPMYLEBSA-N (2s)-2-[[(2s)-6-amino-2-[[(2s,3r)-2-[[(2s,3r)-2-[[(2s)-6-amino-2-(tetradecanoylamino)hexanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxybutanoyl]amino]hexanoyl]amino]-3-hydroxypropanoic acid Chemical compound CCCCCCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O XLELDISCQSKJES-IPPMYLEBSA-N 0.000 claims description 2
- 229940015975 1,2-hexanediol Drugs 0.000 claims description 2
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 claims description 2
- 239000004475 Arginine Substances 0.000 claims description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims description 2
- 229920002101 Chitin Polymers 0.000 claims description 2
- 229920000858 Cyclodextrin Polymers 0.000 claims description 2
- PHOQVHQSTUBQQK-SQOUGZDYSA-N D-glucono-1,5-lactone Chemical compound OC[C@H]1OC(=O)[C@H](O)[C@@H](O)[C@@H]1O PHOQVHQSTUBQQK-SQOUGZDYSA-N 0.000 claims description 2
- MVORZMQFXBLMHM-QWRGUYRKSA-N Gly-His-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CN=CN1 MVORZMQFXBLMHM-QWRGUYRKSA-N 0.000 claims description 2
- 244000068988 Glycine max Species 0.000 claims description 2
- 235000010469 Glycine max Nutrition 0.000 claims description 2
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims description 2
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 claims description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 claims description 2
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 claims description 2
- 108010039918 Polylysine Proteins 0.000 claims description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 2
- 235000021307 Triticum Nutrition 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 2
- 229960003237 betaine Drugs 0.000 claims description 2
- 229960004494 calcium gluconate Drugs 0.000 claims description 2
- 239000004227 calcium gluconate Substances 0.000 claims description 2
- 235000013927 calcium gluconate Nutrition 0.000 claims description 2
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 claims description 2
- 229940100524 ethylhexylglycerin Drugs 0.000 claims description 2
- 235000012209 glucono delta-lactone Nutrition 0.000 claims description 2
- 229960003681 gluconolactone Drugs 0.000 claims description 2
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims description 2
- -1 hydroxypropyl cyclodextrin Chemical compound 0.000 claims description 2
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims description 2
- 229960000367 inositol Drugs 0.000 claims description 2
- 235000014655 lactic acid Nutrition 0.000 claims description 2
- 239000004310 lactic acid Substances 0.000 claims description 2
- 229940078015 myristoyl pentapeptide-4 Drugs 0.000 claims description 2
- OEIJHBUUFURJLI-UHFFFAOYSA-N octane-1,8-diol Chemical compound OCCCCCCCCO OEIJHBUUFURJLI-UHFFFAOYSA-N 0.000 claims description 2
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 claims description 2
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 claims description 2
- 239000002304 perfume Substances 0.000 claims description 2
- 229940068041 phytic acid Drugs 0.000 claims description 2
- 239000000467 phytic acid Substances 0.000 claims description 2
- 235000002949 phytic acid Nutrition 0.000 claims description 2
- 229920000656 polylysine Polymers 0.000 claims description 2
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims description 2
- 229940069755 soybean germ extract Drugs 0.000 claims description 2
- 239000004909 Moisturizer Substances 0.000 claims 1
- 240000004534 Scutellaria baicalensis Species 0.000 claims 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 claims 1
- 241000209140 Triticum Species 0.000 claims 1
- 230000001333 moisturizer Effects 0.000 claims 1
- 210000003780 hair follicle Anatomy 0.000 abstract description 8
- 210000003491 skin Anatomy 0.000 abstract description 8
- 206010061218 Inflammation Diseases 0.000 abstract description 4
- 230000004054 inflammatory process Effects 0.000 abstract description 4
- 231100000331 toxic Toxicity 0.000 abstract description 4
- 230000002588 toxic effect Effects 0.000 abstract description 4
- 239000000686 essence Substances 0.000 description 25
- 230000003803 hair density Effects 0.000 description 14
- 230000006872 improvement Effects 0.000 description 12
- 201000004384 Alopecia Diseases 0.000 description 10
- 231100000360 alopecia Toxicity 0.000 description 9
- 210000003128 head Anatomy 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 6
- 210000004761 scalp Anatomy 0.000 description 6
- 241000218657 Picea Species 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 230000028327 secretion Effects 0.000 description 5
- 210000002374 sebum Anatomy 0.000 description 4
- 235000003392 Curcuma domestica Nutrition 0.000 description 3
- 108010076876 Keratins Proteins 0.000 description 3
- 235000008124 Picea excelsa Nutrition 0.000 description 3
- 235000003373 curcuma longa Nutrition 0.000 description 3
- 229920001184 polypeptide Polymers 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 235000013976 turmeric Nutrition 0.000 description 3
- 239000013543 active substance Substances 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000003648 hair appearance Effects 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 239000000516 sunscreening agent Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 206010016936 Folliculitis Diseases 0.000 description 1
- 206010019049 Hair texture abnormal Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- NEAPKZHDYMQZCB-UHFFFAOYSA-N N-[2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]ethyl]-2-oxo-3H-1,3-benzoxazole-6-carboxamide Chemical compound C1CN(CCN1CCNC(=O)C2=CC3=C(C=C2)NC(=O)O3)C4=CN=C(N=C4)NC5CC6=CC=CC=C6C5 NEAPKZHDYMQZCB-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- 244000184734 Pyrus japonica Species 0.000 description 1
- 206010039509 Scab Diseases 0.000 description 1
- 241000207929 Scutellaria Species 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 235000012754 curcumin Nutrition 0.000 description 1
- 229940109262 curcumin Drugs 0.000 description 1
- 239000004148 curcumin Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 208000024963 hair loss Diseases 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000001272 neurogenic effect Effects 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 235000013974 saffron Nutrition 0.000 description 1
- 239000004248 saffron Substances 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/736—Chitin; Chitosan; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/738—Cyclodextrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/88—Polyamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9755—Gymnosperms [Coniferophyta]
- A61K8/9767—Pinaceae [Pine family], e.g. pine or cedar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/30—Characterized by the absence of a particular group of ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cosmetics (AREA)
Abstract
本发明涉及头发护理产品领域，公开了一种具有固发、生发功效的精华液及其制备方法，所述精华液包括A相组分、B相组分、C相组分、D相组分和溶剂，以重量百分比计，A相组分包括：保湿剂1.51～30.5％、增稠剂0.11～2％；B相组分包括：保湿剂0.01～0.5％、植物促渗剂0.05～1.5％、中和剂0.01～0.5％；C相组分包括：生发剂0.2～13％、毛发生长剂0.1～3％、固发生发剂0.1～6％、控油消炎剂1～50％、抗敏修护剂0.05～2％；所述控油消炎剂包括挪威云杉叶提取物，所述抗敏修护剂包括水、1，3－丙二醇、番红花提取物；D相组分包括：芳香剂0.001～0.2％、防腐剂0.1～1％；余量为溶剂。本发明所提供的精华液安全性高，天然环保，对头部皮肤无毒副作用，可改善毛囊炎症，起到固发、生发的功效。
Description
技术领域
本发明涉及护发养发产品领域，特别是涉及一种具有固发、生发功效的精华液及其制备方法。
背景技术
脱发的原因主要有神经性脱发、脂溢性脱发以及由于气血不足所引起的中老年脱发、病后产后脱发等。其中脂溢性脱发是过多的皮脂分泌物堆积在毛囊周围，甚至压迫或堵塞毛囊孔，给毛发正常生长制造障碍，此外，皮脂分泌物中的油酸、亚油酸等过量时对毛囊有毒性作用，导致毛发中毒、枯萎、脱落。脂溢性脱发多发生于皮脂腺分泌旺盛的青壮年，逐渐自头顶开始脱发，蔓延至额部。头皮油腻而亮红，结黄色油性痂。
目前市场上的固发生发产品存在以下缺点：1、产品的安全性评分都比较低；2、所含有效成分比较少，一般只含1－2个有效成分，其它均为辅助性成分，对固发及生发作用效果不大；3、含有化学防腐剂，对头部皮肤伤害性大，甚至存在部分产品含有防晒剂，会进一步损伤头部皮肤；4、纯植物提炼的活性物质的添加量比较少，产品对头部皮肤的刺激性比较大。
发明内容
本发明的目的在于克服上述现有技术的不足之处而提供一种具有固发、生发功效的精华液及其制备方法，安全性高，天然环保，对头部皮肤无毒副作用，可改善毛囊炎症，起到固发、生发的功效。
为了实现上述目的，本发明提供的技术方案为：
一种具有固发、生发功效的精华液，包括A相组分、B相组分、C相组分、D相组分和溶剂，以重量百分比计，所述A相组分包括：保湿剂1.51～30.5％、增稠剂0.11～2％；
所述B相组分包括：保湿剂0.01～0.5％、植物促渗剂0.05～1.5％、中和剂0.01～0.5％；
所述C相组分包括：生发剂0.2～13％、毛发生长剂0.1～3％、固发生发剂0.1～6％、控油消炎剂1～50％、抗敏修护剂0.05～2％；所述控油消炎剂包括挪威云杉叶提取物，所述抗敏修护剂包括水、1，3－丙二醇、番红花提取物；
所述D相组分包括：芳香剂0.001～0.2％、防腐剂0.1～1％；
余量为溶剂。
作为上述方案的进一步改进，所述A相组分中，以重量百分比计，所述保湿剂包括丁二醇1～20％、聚甘油－10 0.5～10％和EDTA二钠0.01～0.5％；所述增稠剂包括丙烯酰二甲基牛磺酸铵/山嵛醇聚醚－25甲基丙烯酸酯交联聚合物0.01～1％、卡波姆U20 0.1～1％。
作为上述方案的进一步改进，以重量百分比计，所述丁二醇的含量为5％，所述聚甘油－10的含量为2％，所述EDTA二钠的含量为0.05％；所述丙烯酰二甲基牛磺酸铵/山嵛醇聚醚－25甲基丙烯酸酯交联聚合物的含量为0.025％，所述卡波姆U20的含量为0.375％。
作为上述方案的进一步改进，所述B相组分中，保湿剂包括水解透明质酸钠，植物促渗剂包括四氢胡椒碱、肌醇、羟丙基环糊精、聚赖氨酸、甜菜碱、水解壳多糖、甘油、丁二醇，中和剂包括三乙醇胺。
作为上述方案的进一步改进，以重量百分比计，所述保湿剂的含量为0.1％，所述植物促渗剂的含量为0.5％，所述中和剂的含量为0.2％。
作为上述方案的进一步改进，所述C相组分中，以重量百分比计，生发剂包括第一生发剂0.1～10％、第二生发剂0.1～3％，所述第一生发剂包括1，3－丙二醇、水、精氨酸、乳酸、野大豆胚芽提取物、小麦胚芽提取物、黄芩根提取物、葡糖酸内酯、葡萄糖酸钙；所述第二生发剂包括姜黄根茎提取物、水、1，2－戊二醇、肌醇六磷酸。
作为上述方案的进一步改进，以重量百分比计，所述第一生发剂的含量为5％，所述第二生发剂的含量为1％。
作为上述方案的进一步改进，所述C相组分中，以重量百分比计，所述毛发生长剂的含量为1％，毛发生长剂包括水、甘油、肉豆蔻酰五肽－4、三肽－1、辛二醇、乙基己基甘油；所述固发生发剂的含量为2％，固发生发剂包括丙二醇、甘油、余甘子果提取物；所述控油消炎剂的含量为20％；所述抗敏修护剂的含量为0.5％。
作为上述方案的进一步改进，所述溶剂为水；所述D相组分中，芳香剂包括香精和/或香料，防腐剂包括丁二醇、1，2－己二醇、辛酰羟肟酸。
具体而言，本发明所述具有固发、生发功效的精华液的配方表如下：
本发明第二方面提供如上所述的具有固发、生发功效的精华液的制备方法，所述制备方法包括：将溶剂加入锅中升温至80℃后加入A相组分，搅拌均质分散，升温至86～90℃，保温30～40分钟，得到混合物A，将混合物A降温至60～65℃后加入B相组分，B相组分用水溶解分散加入，得到混合物B，将混合物B降温至38～40℃时加入C相组分，搅拌降温至38℃以下时再加入D相组分，最后搅拌30～40分钟即得所述具有固发、生发功效的精华液。
与现有技术相比，本发明的有益效果在于：
1、本发明所提供的具有固发、生发功效的精华液添加多种纯天然植物成分，天然环保，安全性高，对头部皮肤无毒副作用和刺激性，可改善毛囊炎症，起到固发、生发的功效；
2、精华液中添加高含量的植物成分，其中挪威云杉(PICEA EXCELSA)叶提取物为纯天然植物来源的消炎剂，在起控油、消炎效果的同时自带植物中药香气，提升产品的使用体感；
3、使用时通过微小分子透明质酸钠和极易吸收的配方体系有效地将挪威云杉(PICEA EXCELSA)叶提取物和番红花(CROCUS SATIVUS)提取物渗入至皮肤的真皮层，从而将解决毛囊炎症问题并修复头部皮肤；
4、精华液中添加了含量为5～10％的天然植物促渗剂(四氢胡椒碱等成分)，在涂抹按摩过程将73800－BAICAPILTM复活植物生发剂、EMGPEPTIDE－MP17、CAPILIA LONG－CPPF(姜黄生发植物多肽)、71900－KERASCALPIM(余甘子头皮焕活因子)等有效活性物渗透至头发根部，修护受损发根；
5、本发明的精华液未添加任何化学防腐剂和防晒剂，产品安全可靠，不损伤头部皮肤。
附图说明
图1是本发明第二效果实施例中志愿受试者使用产品前的头发状态示意图；
图2是本发明第二效果实施例中志愿受试者使用产品后的头发状态示意图。
具体实施方式
为更好的说明本发明的目的、技术方案和优点，下面将结合具体实施例对本发明作进一步说明。
本发明提供一种具有固发、生发功效的精华液，其配方表如下：
其中，EMGPEPTIDE－MP17作为信号胜肽之一，可以明显活化角质蛋白基因，促进其表达，从而引导细胞的发育生长以及生长因子的分泌，促进毛发增浓增长。EMGPEPTIDE－MP17可有效刺激毛发重要组成成分角蛋白的合成，促进毛发的生长，从深层修复受损毛发，使毛发更加浓密、坚韧。
CAPILIA LONG－C PPF(姜黄生发植物多肽)中，姜黄富含类姜黄色素(主要是姜黄素)，是当今生物医学方面研究最多的植物之一，被称之为“头发3D生物打印机”，是最佳的头发护理成分之一；姜黄生发植物多肽可防止和减少脱发，刺激头发生长，增加头发密度，对头发有滋养和巩固效果，可特别针对易断、脆弱头发。
余甘子中的阿育吠陀草药成分，可维持干细胞健康状态从而恢复头发和头皮的活力，防止毛囊退化(微型化)，让头皮充满活力，强韧脆弱头发，使头发更有光泽。
北极光黑云杉树汁为百分百天然植物原料，可分解皮脂，起抗菌功效，用于头发护理中，可起到头皮控油和改善毛囊炎的效果。
实施例与对比例：
制备方法包括：将溶剂加入锅中升温至80℃后加入A相组分，搅拌均质分散，升温至86～90℃，保温30～40分钟，得到混合物A，将混合物A降温至60～65℃后加入B相组分，B相组分用水溶解分散加入，得到混合物B，将混合物B降温至38～40℃时加入C相组分，搅拌降温至38℃以下时再加入D相组分，最后搅拌30～40分钟即得所述具有固发、生发功效的精华液。
第一效果实施例：
一、人体测试试验
1、实验要求：18至60岁拥有地中海高加索发质的志愿者(男性和女性)参加了本次试验评估。
2、受试样品：本发明实施例1－6及对比例1制备得到的具有固发、生发功效的精华液。
3、实验方法：选取105名(18至60岁)志愿受试者，将所有志愿受试者随机分成7组，每组15人。各组志愿受试者分别使用上述受试样品，每天早晚各一次，在使用前和使用后180天做对比，记录观察结果。
使用180天后通过微型摄像机评估志愿受试者的头发密度(头发密度＝每单位面积(cm2)的头发数量)，结果如下表所示。
如上表所示，实施例1组在使用后头发密度增加了77.78％，实施例2组在使用后头发密度增加了295.16％，实施例3组在使用后头发密度增加了54.26％，实施例4组在使用后头发密度增加了104.11％，实施例5组在使用后头发密度增加了88.37％，实施例6组在使用后头发密度增加了125.53％，各实施例组头发密度的平均百分比增加值为124.20％，对比例1组在使用后头发密度增加了70.83％，证明了本发明所提供的精华液具有显著的生发及固发功效，而且在添加了73800－BAICAPILTM复活植物生发剂和Sens＇flower SD－SC(藏红花360舒敏因子)后，其生发及固发功效提升更为明显。
第二效果实施例：
本实施例针对实施例2，对实施例2制备得到的具有固发、生发功效的精华液再进行一次使用试验。
1、试验要求：选取18至60岁拥有地中海高加索发质的志愿受试者(男性和女性)参加本次试验评估。
2、受试样品：本发明实施例2制备得到的具有固发、生发功效的精华液。
3、试验方法：选取61名(18至60岁)志愿受试者，使用实施例2受试样品，每天早晚各一次，在使用前和使用90天后做对比，记录观察结果。如图1(a)、(b)所示，图1(a)显示志愿受试者的头发发根状态，图1(b)显示志愿受试者的头发密度，在使用本发明实施例2所提供的精华液之前，志愿受试者的头发发根较脆弱，头发也较为稀疏，但在使用了本发明实施例2的精华液90天后，如图2(a)、(b)所示，图2(a)显示志愿受试者使用后的头发发根状态，图2(b)显示志愿受试者使用后的头发密度，图中显示志愿受试者在使用了实施例2的精华液后头发变得坚韧，而且头发密度显著提高。
第三效果实施例：
本实施例验证产品使用后的感官评价。
1、受试样品：本发明实施例1－6及对比例1制备得到的具有固发、生发功效的精华液。
2、试验方法：选取120名(18－50岁)出现脱发、掉发、头发呈干枯状态的志愿受试者参加试验，将所有志愿受试者随机分成4组，每组30人。各组志愿受试者分别试用实施例1－6及对比例1的精华液，每天早晚各试用一次，连续试用90天。
试用结束后，各志愿受试者就固发改善效果、生发改善效果、产品质地度、气味等方面做出评价，根据使用效果在0－10分之间打分，9－10分为很好，7－9分为较好，4－7分为一般，2－4分为较差，0－2分为很差，取平均值，结果如下表所示：
| 组别 | 固发改善效果 | 生发改善效果 | 质地接受 | 气味接受 |
| 实施例1 | 7 | 7 | 8 | 8 |
| 实施例2 | 9 | 8 | 9 | 9 |
| 实施例3 | 6 | 6 | 8 | 7 |
| 实施例4 | 6 | 7 | 7 | 6 |
| 实施例5 | 7 | 7 | 6 | 7 |
| 实施例6 | 7 | 7 | 6 | 7 |
| 对比例1 | 6 | 7 | 6 | 7 |
从上表可以看出，实施例1－6组固发改善效果的平均评分为7.0，生发改善效果的平均评分为7.0，质地接受度的平均评分为7.3，气味接受度的平均评分为7.3，结果表明本发明精华液的固发改善效果、生发改善效果、质地接受度、气味接受度等感官评价均为较好。
以上所述仅是本发明的优选实施方式，应当指出，对于本技术领域的普通技术人员来说，在不脱离本发明技术原理的前提下，还可以做出若干改进和替换，这些改进和替换也应视为本发明的保护范围。
Claims (10)
1.一种具有固发、生发功效的精华液，其特征在于，包括A相组分、B相组分、C相组分、D相组分和溶剂，以重量百分比计，所述A相组分包括：保湿剂1.51～30.5％、增稠剂0.11～2％；
所述B相组分包括：保湿剂0.01～0.5％、植物促渗剂0.05～1.5％、中和剂0.01～0.5％；
所述C相组分包括：生发剂0.2～13％、毛发生长剂0.1～3％、固发生发剂0.1～6％、控油消炎剂1～50％、抗敏修护剂0.05～2％；所述控油消炎剂包括挪威云杉叶提取物，所述抗敏修护剂包括水、1，3－丙二醇、番红花提取物；
所述D相组分包括：芳香剂0.001～0.2％、防腐剂0.1～1％；
余量为溶剂。
2.根据权利要求1所述的具有固发、生发功效的精华液，其特征在于，所述A相组分中，以重量百分比计，所述保湿剂包括丁二醇1～20％、聚甘油－100.5～10％和EDTA二钠0.01～0.5％；所述增稠剂包括丙烯酰二甲基牛磺酸铵/山嵛醇聚醚－25甲基丙烯酸酯交联聚合物0.01～1％、卡波姆U20 0.1～1％。
3.根据权利要求2所述的具有固发、生发功效的精华液，其特征在于，以重量百分比计，所述丁二醇的含量为5％，所述聚甘油－10的含量为2％，所述EDTA二钠的含量为0.05％；所述丙烯酰二甲基牛磺酸铵/山嵛醇聚醚－25甲基丙烯酸酯交联聚合物的含量为0.025％，所述卡波姆U20的含量为0.375％。
4.根据权利要求1所述的具有固发、生发功效的精华液，其特征在于，所述B相组分中，保湿剂包括水解透明质酸钠，植物促渗剂包括四氢胡椒碱、肌醇、羟丙基环糊精、聚赖氨酸、甜菜碱、水解壳多糖、甘油、丁二醇，中和剂包括三乙醇胺。
5.根据权利要求4所述的具有固发、生发功效的精华液，其特征在于，以重量百分比计，所述保湿剂的含量为0.1％，所述植物促渗剂的含量为0.5％，所述中和剂的含量为0.2％。
6.根据权利要求1所述的具有固发、生发功效的精华液，其特征在于，所述C相组分中，以重量百分比计，生发剂包括第一生发剂0.1～10％、第二生发剂0.1～3％，所述第一生发剂包括1，3－丙二醇、水、精氨酸、乳酸、野大豆胚芽提取物、小麦胚芽提取物、黄芩根提取物、葡糖酸内酯、葡萄糖酸钙；所述第二生发剂包括姜黄根茎提取物、水、1，2－戊二醇、肌醇六磷酸。
7.根据权利要求6所述的具有固发、生发功效的精华液，其特征在于，以重量百分比计，所述第一生发剂的含量为5％，所述第二生发剂的含量为1％。
8.根据权利要求1所述的具有固发、生发功效的精华液，其特征在于，所述C相组分中，以重量百分比计，所述毛发生长剂的含量为1％，毛发生长剂包括水、甘油、肉豆蔻酰五肽－4、三肽－1、辛二醇、乙基己基甘油；所述固发生发剂的含量为2％，固发生发剂包括丙二醇、甘油、余甘子果提取物；所述控油消炎剂的含量为20％；所述抗敏修护剂的含量为0.5％。
9.根据权利要求1所述的具有固发、生发功效的精华液，其特征在于，所述溶剂为水；所述D相组分中，芳香剂包括香精和/或香料，防腐剂包括丁二醇、1，2－己二醇、辛酰羟肟酸。
10.根据权利要求1～9任一项所述的具有固发、生发功效的精华液的制备方法，其特征在于，包括：将溶剂加入锅中升温至80℃后加入A相组分，搅拌均质分散，升温至86～90℃，保温30～40分钟，得到混合物A，将混合物A降温至60～65℃后加入B相组分，B相组分用水溶解分散加入，得到混合物B，将混合物B降温至38～40℃时加入C相组分，搅拌降温至38℃以下时再加入D相组分，最后搅拌30～40分钟即得所述具有固发、生发功效的精华液。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110562477.9A CN113318043A (zh) | 2021-05-21 | 2021-05-21 | 一种具有固发、生发功效的精华液及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110562477.9A CN113318043A (zh) | 2021-05-21 | 2021-05-21 | 一种具有固发、生发功效的精华液及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113318043A true CN113318043A (zh) | 2021-08-31 |
Family
ID=77416386
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110562477.9A Pending CN113318043A (zh) | 2021-05-21 | 2021-05-21 | 一种具有固发、生发功效的精华液及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113318043A (zh) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114042022A (zh) * | 2021-11-16 | 2022-02-15 | 滁州植兀生物科技有限公司 | 一种防脱组合物和防脱洗护产品及制备方法 |
| CN114099635A (zh) * | 2021-11-19 | 2022-03-01 | 烟台魔技纳米科技有限公司 | 一种可溶性生发微针及其制备方法 |
| CN114288229A (zh) * | 2022-01-07 | 2022-04-08 | 广州市渝崧精细化工有限公司 | 一种祛痘组合物及其制备方法及其应用 |
| CN114939086A (zh) * | 2022-06-24 | 2022-08-26 | 羽楠(广州)化妆品有限公司 | 一种零油面霜及其制备方法 |
| CN115120548A (zh) * | 2022-07-11 | 2022-09-30 | 广州市韵柯莱化妆品科技有限公司 | 一种长效保湿修复水及其制备方法 |
| CN117959232A (zh) * | 2024-03-29 | 2024-05-03 | 珠海博御中医药研究有限公司 | 一种乌发精华液组合物及其制备方法和应用 |
| CN118121523A (zh) * | 2024-05-06 | 2024-06-04 | 珠海博御中医药研究有限公司 | 一种乌发、育发功效精华液组合物及其制备方法和应用 |
| CN118121523B (zh) * | 2024-05-06 | 2024-07-16 | 珠海博御中医药研究有限公司 | 一种乌发、育发功效精华液组合物及其制备方法和应用 |
Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1203076A (zh) * | 1997-06-23 | 1998-12-30 | 郑齐 | 一种余甘子洗浴液 |
| WO2016046848A2 (en) * | 2014-09-26 | 2016-03-31 | Brillare Science Pvt Ltd. | Novel formulation of concentrated natural actives in oil-water microemulsion for hair fall prevention and increase in hair density |
| CN106880693A (zh) * | 2017-03-22 | 2017-06-23 | 广州国草夏方生物科技有限公司 | 一种治疗脂溢性脱发的生发液组合物及其制备方法 |
| CN109674722A (zh) * | 2019-01-31 | 2019-04-26 | 广州艾蓓生物科技有限公司 | 一种防脱生发精华液及其制备方法 |
| CN110200837A (zh) * | 2019-06-20 | 2019-09-06 | 华熙生物科技股份有限公司 | 一种生发组合物 |
| CN110339119A (zh) * | 2019-08-20 | 2019-10-18 | 广州臻颜化妆品有限公司 | 一种抗敏舒缓面膜及其制备方法 |
| CN110368341A (zh) * | 2019-07-10 | 2019-10-25 | 广东盛美化妆品有限公司 | 一种含高山植物提取物的健发营养液及其制备方法 |
| CN110664670A (zh) * | 2019-10-24 | 2020-01-10 | 吴文育 | 蔓森思舒缓控油洗发水 |
| CN112516006A (zh) * | 2020-12-10 | 2021-03-19 | 武汉百思凯瑞生物科技有限公司 | 一种具有防脱生发、固发、黑发功能的纳米组合物及其制备方法和应用 |
-
2021
- 2021-05-21 CN CN202110562477.9A patent/CN113318043A/zh active Pending
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1203076A (zh) * | 1997-06-23 | 1998-12-30 | 郑齐 | 一种余甘子洗浴液 |
| WO2016046848A2 (en) * | 2014-09-26 | 2016-03-31 | Brillare Science Pvt Ltd. | Novel formulation of concentrated natural actives in oil-water microemulsion for hair fall prevention and increase in hair density |
| CN106880693A (zh) * | 2017-03-22 | 2017-06-23 | 广州国草夏方生物科技有限公司 | 一种治疗脂溢性脱发的生发液组合物及其制备方法 |
| CN109674722A (zh) * | 2019-01-31 | 2019-04-26 | 广州艾蓓生物科技有限公司 | 一种防脱生发精华液及其制备方法 |
| CN110200837A (zh) * | 2019-06-20 | 2019-09-06 | 华熙生物科技股份有限公司 | 一种生发组合物 |
| CN110368341A (zh) * | 2019-07-10 | 2019-10-25 | 广东盛美化妆品有限公司 | 一种含高山植物提取物的健发营养液及其制备方法 |
| CN110339119A (zh) * | 2019-08-20 | 2019-10-18 | 广州臻颜化妆品有限公司 | 一种抗敏舒缓面膜及其制备方法 |
| CN110664670A (zh) * | 2019-10-24 | 2020-01-10 | 吴文育 | 蔓森思舒缓控油洗发水 |
| CN112516006A (zh) * | 2020-12-10 | 2021-03-19 | 武汉百思凯瑞生物科技有限公司 | 一种具有防脱生发、固发、黑发功能的纳米组合物及其制备方法和应用 |
Non-Patent Citations (3)
| Title |
|---|
| 广州诺然: "抓住升级，甩掉"脱发"困扰", 《搜狗微信检索》 * |
| 新设技: "真正德国品牌，植物生发黑科技-安全有效拯救脱发，没有之一！", 《搜狐网》 * |
| 荣格: "新品首发！1款非传统植物促渗剂", 《HTTPS://WWW.INDUSTRYSOURCING.CN/CLIENT/ARTICLE/DETAILS.HTML?ID=404049》 * |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114042022A (zh) * | 2021-11-16 | 2022-02-15 | 滁州植兀生物科技有限公司 | 一种防脱组合物和防脱洗护产品及制备方法 |
| CN114099635A (zh) * | 2021-11-19 | 2022-03-01 | 烟台魔技纳米科技有限公司 | 一种可溶性生发微针及其制备方法 |
| CN114288229A (zh) * | 2022-01-07 | 2022-04-08 | 广州市渝崧精细化工有限公司 | 一种祛痘组合物及其制备方法及其应用 |
| CN114939086A (zh) * | 2022-06-24 | 2022-08-26 | 羽楠(广州)化妆品有限公司 | 一种零油面霜及其制备方法 |
| CN115120548A (zh) * | 2022-07-11 | 2022-09-30 | 广州市韵柯莱化妆品科技有限公司 | 一种长效保湿修复水及其制备方法 |
| CN117959232A (zh) * | 2024-03-29 | 2024-05-03 | 珠海博御中医药研究有限公司 | 一种乌发精华液组合物及其制备方法和应用 |
| CN117959232B (zh) * | 2024-03-29 | 2024-06-11 | 珠海博御中医药研究有限公司 | 一种乌发精华液组合物及其制备方法和应用 |
| CN118121523A (zh) * | 2024-05-06 | 2024-06-04 | 珠海博御中医药研究有限公司 | 一种乌发、育发功效精华液组合物及其制备方法和应用 |
| CN118121523B (zh) * | 2024-05-06 | 2024-07-16 | 珠海博御中医药研究有限公司 | 一种乌发、育发功效精华液组合物及其制备方法和应用 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN113318043A (zh) | 一种具有固发、生发功效的精华液及其制备方法 | |
| KR101237316B1 (ko) | 두피두발용 조성물 | |
| KR101997177B1 (ko) | 두피 및 모발 상태 개선용 샴푸 조성물 | |
| CN109674722B (zh) | 一种防脱生发精华液及其制备方法 | |
| CN106236644A (zh) | 一种水嫩润透精华液 | |
| JP6977233B2 (ja) | 頭部用組成物 | |
| KR20120012904A (ko) | 유방확대 또는 피부탄력 향상을 위한 화장료 조성물 | |
| CN111374920A (zh) | 纯天然洗发护发保湿修复组合物及其制备方法 | |
| CN109806194A (zh) | 一种祛痘凝胶及其制备方法 | |
| CN115120547A (zh) | 一种无刺激毛发修护组合物及防脱洗发露 | |
| CN112137904A (zh) | 一种幻彩水光肌底精华液及其制备方法 | |
| KR20150105091A (ko) | 발효식물을 이용한 화장료 조성물과 이의 제조방법 그리고 이를 이용한 헤어샴푸 | |
| CN108078854A (zh) | 一种保湿修复手霜及其制备方法 | |
| KR102094846B1 (ko) | 피부 개선에 효능이 있는 혼합생약 화장료 조성물의 제조방법 및 이를 통해 제조된 혼합생약 화장료 조성물 | |
| CN110664684A (zh) | 一种羊胎素保湿抗衰老精华液及其制备工艺 | |
| CN107224418B (zh) | 一种天然助眠美容面膜及其制备方法 | |
| JP3991164B2 (ja) | ナツメ抽出物および胡桃抽出物を含む化粧料組成物 | |
| KR102303252B1 (ko) | 탈모 방지 및 발모 개선용 모발 화장료 조성물 | |
| KR101547758B1 (ko) | 탈모 예방 및 양모, 육모 촉진용 조성물 | |
| CN116785218A (zh) | 一种补水保湿润肤组合物及其在化妆品中的应用 | |
| KR100980215B1 (ko) | 두피 각질 제거 또는 비듬 개선을 위한 조성물 | |
| KR101956749B1 (ko) | 혼합생약 화장료 조성물의 제조방법 및 이를 통해 제조된 혼합생약 화장료 조성물 | |
| KR20210048993A (ko) | 락토바실러스 발효물을 포함하는 모발 화장료 조성물 | |
| CN111956521A (zh) | 一种护发组合物及其应用，采用该组合物的护发素和头皮精华及其制备方法 | |
| CN112569146A (zh) | 一种含有雪绒花提取物的美白化妆品 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210831 |
|
| RJ01 | Rejection of invention patent application after publication |